Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification

NCT03106155 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Decision of IP support organization

Conditions

Small Cell Lung Cancer

Interventions

DRUG: vistusertib (AZD2014)

Sponsor

Samsung Medical Center

Collaborators

[object Object]